On October 2, CSPC PHARMA fell 3.13% in regular trading, trading at HK$9.735 per share, with turnover of HK$68.23 million.

Within the Pharmaceuticals sector where CSPC PHARMA belongs, the overall sector moved lower. Among individual stocks, HANSOH PHARMA down 4.42%, HENGRUI PHARMA down 3.86%, SBP GROUP down 3.77%, ASYMCHEM down 5.34%, SIMCERE PHARMA down 4.56%.

CSPC Pharmaceutical Group Limited is a company principally engaged in the production and sale of pharmaceutical products. Its products mainly cover therapeutic areas including neurology, oncology, anti-infectives, cardiovascular, respiratory, digestive and metabolic systems, among others. The company sells its products in both domestic and international markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)